Articles from Median Technologies

Median Technologies: Financial Communications Schedule for the First Half of 2025
Regulatory News:
By Median Technologies · Via Business Wire · January 14, 2025
Median Technologies to Showcase AI-Powered Lung Cancer Diagnostic eyonis™ LCS at the Radiological Society of North America (RSNA) 2024
Regulatory News:
By Median Technologies · Via Business Wire · November 26, 2024
Median Technologies Hosted Insightful Key Opinion Leader (KOL) Webinar on eyonis™ Lung Cancer Screening (LCS) REALITY Data
Regulatory News:
By Median Technologies · Via Business Wire · November 7, 2024
Median Technologies to Host Key Opinion Leader (KOL) Webinar on AI and Lung Cancer Screening
Regulatory News:
By Median Technologies · Via Business Wire · October 30, 2024
Median Technologies Reports 2024 Q3 Operational and Financial Update and 2024 Half-Year Results
Regulatory News:
By Median Technologies · Via Business Wire · October 24, 2024
Median Technologies to Attend and Present at the ESMO Congress 2024, Being Held in Barcelona, Spain, from Sept 13-17, 2024
Regulatory News:
By Median Technologies · Via Business Wire · September 11, 2024
Median Technologies to share positive pivotal data for eyonis™ LCS diagnostic software as medical device at the IASLC 2024 World Conference on Lung Cancer
Regulatory News:
By Median Technologies · Via Business Wire · September 4, 2024
Median Technologies to host two webcasts on September 5, 2024
Regulatory News:
By Median Technologies · Via Business Wire · September 2, 2024
Median Technologies Announces Pivotal REALITY Study of Its eyonis™ LCS Lung Cancer Diagnostic Met All Primary and Secondary Endpoints
Regulatory News:
By Median Technologies · Via Business Wire · August 29, 2024
Median Technologies Partners with a Top 10 Oncology Pharma Company to Apply AI for Imaging Biomarker Discovery
Regulatory News:
By Median Technologies · Via Business Wire · August 6, 2024
Median Technologies Reports Record iCRO Backlog, eyonis™ LCS On-Track for Standalone Pivotal Study Readout in August
Regulatory News:
By Median Technologies · Via Business Wire · July 18, 2024
Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of May 31st, 2024
Regulatory News:
By Median Technologies · Via Business Wire · June 7, 2024
Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 19, 2024
Regulatory News:
By Median Technologies · Via Business Wire · June 3, 2024
Median Technologies to Participate in the 2024 ASCO Annual Meeting, May 31 - June 4, 2024, McCormick Place, Chicago, IL, USA
Regulatory News:
By Median Technologies · Via Business Wire · May 29, 2024
Median Technologies, a World Leading Oncology Clinical Trial Imaging Services Provider, Becomes Preferred Vendor to Another Top 3 Pharmaceutical Company
Regulatory News:
By Median Technologies · Via Business Wire · May 21, 2024
Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information
Regulatory News:
By Median Technologies · Via Business Wire · April 25, 2024
Median Technologies to Participate in the TD Cowen’s 44th Annual Health Care Conference
Regulatory News:
By Median Technologies · Via Business Wire · February 29, 2024
Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 – March 3, Vienna, Austria
Regulatory News:
By Median Technologies · Via Business Wire · February 26, 2024
Median Technologies Reports 2023 Revenue and Summarizes 2024 Strategic Outlook
Regulatory News:
By Median Technologies · Via Business Wire · January 29, 2024
New Date for Median Technologies’ Webcasts: February 1st, 2024
Regulatory News:
By Median Technologies · Via Business Wire · January 26, 2024
Median Technologies to Host Two Webcasts, and Provide a Company Update on January 30, 2024
Regulatory News:
By Median Technologies · Via Business Wire · January 25, 2024
Median Technologies Announces the Drawdown of €8.5m Corresponding to the Final Tranche of the European Investment Bank Loan
Regulatory News:
By Median Technologies · Via Business Wire · December 27, 2023
Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine
Regulatory News:
By Median Technologies · Via Business Wire · December 14, 2023
Median Technologies to Speak at the IASLC 2023 North America Conference on Lung Cancer (NACLC), Dec. 1-3, Chicago, IL, USA, with two Presentations
Regulatory News:
By Median Technologies · Via Business Wire · November 30, 2023
Median Technologies Selected for Support Under the French Government's ETIncelles Program
Regulatory News:
By Median Technologies · Via Business Wire · November 27, 2023
Median Technologies Announces Rebranding of iBiopsy®, Changes Name to eyonis™
Regulatory News:
By Median Technologies · Via Business Wire · November 26, 2023
Median Technologies to Speak at the Radiological Society of North America 2023 Annual Meeting, Nov. 26 - 30, Chicago, IL, USA
Regulatory News:
By Median Technologies · Via Business Wire · November 22, 2023
Median Technologies Reports 2023 Half-year Results and Business Indicators for the Third Quarter of 2023
Regulatory News:
By Median Technologies · Via Business Wire · October 19, 2023
First Results of Median Technologies’ iBiopsy® HCC Detection AI Model Developed on the PHELICAR Clinical Data Registry, to Be Presented at the ESMO Congress (Oct 20-24, 2023, Madrid, Spain)
Regulatory News:
By Median Technologies · Via Business Wire · October 17, 2023
Median Technologies’ Global iCRO Team to participate in the 2023 ESMO Congress, Oct 20 – 24, 2023, Madrid, Spain
Regulatory News:
By Median Technologies · Via Business Wire · October 16, 2023
Median Technologies Appoints Ben McDonald to its Board of Directors
Median Technologies (Paris:ALMDT) announced today that Ben McDonald has joined its Board of Directors, chaired by Oran Muduroglu. This appointment was approved during the ordinary shareholders’ meeting, held on October 10th.
By Median Technologies · Via Business Wire · October 10, 2023
Median Technologies: Financial Communication Schedule for the Second Half of 2023
Regulatory News:
By Median Technologies · Via Business Wire · July 26, 2023
Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a “Strong Buy” Recommendation
Regulatory News:
By Median Technologies · Via Business Wire · July 21, 2023
Median Technologies to Host Two Webcasts and Provide a Company Update on July 20, 2023
Regulatory News:
By Median Technologies · Via Business Wire · July 17, 2023
Median Technologies Announces Onboarding of All Academic Sites Involved in the Pivotal Validation Plan for iBiopsy® LCS CADe/CADx SaMD
Regulatory News:
By Median Technologies · Via Business Wire · July 17, 2023
Median Technologies Reports Its Business Activity for the First Half of 2023 and Announces the First Step of Its Refinancing Plan
Regulatory News:
By Median Technologies · Via Business Wire · July 12, 2023
Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 20, 2023
Regulatory News:
By Median Technologies · Via Business Wire · May 30, 2023
Median Technologies Reschedules Its Corporate Update Webcasts on May 4, 2023
Regulatory News:
By Median Technologies · Via Business Wire · April 25, 2023
Median Technologies to Host Two Webcasts and Provide a Company Update on May 3, 2023
Regulatory News:
By Median Technologies · Via Business Wire · April 24, 2023
Median Technologies Reports Full-year 2022 Results and Business Indicators for the First Quarter Of 2023
Regulatory News:
By Median Technologies · Via Business Wire · April 20, 2023
Median Technologies to present new and breakthrough results for its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device at the European Congress of Radiology, taking place March 1-5 2023 in Vienna, Austria
Regulatory News:
By Median Technologies · Via Business Wire · February 28, 2023
Median Technologies Announces Completion of the Q-Submission Phase with the FDA for its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device
Regulatory News:
By Median Technologies · Via Business Wire · February 27, 2023
Median Technologies to Participate in the Cowen’s 43rd Annual Health Care Conference
Regulatory News:
By Median Technologies · Via Business Wire · February 23, 2023
Median Technologies to Host Two Webcasts and Provide a Company Update on February 2, 2023
Regulatory News:
By Median Technologies · Via Business Wire · January 24, 2023
Median Technologies Announces 2022 Revenue of €23.8 Million, up 16%, and an Order Backlog of €60.8 Million
Regulatory News:
By Median Technologies · Via Business Wire · January 19, 2023
Median Technologies: Financial Communications Schedule for the First Half of 2023
Regulatory News:
By Median Technologies · Via Business Wire · December 21, 2022
Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 - Dec 1, Chicago, IL, USA, With Three Presentations
Regulatory News:
By Median Technologies · Via Business Wire · November 22, 2022
Median Technologies Announces Its 2022 Half-year Results and Revenues for the Third Quarter
Regulatory News:
By Median Technologies · Via Business Wire · October 20, 2022
Median Technologies Announces Formation of Clinical Advisory Board for iBiopsy® Lung Cancer Screening
Regulatory News:
By Median Technologies · Via Business Wire · October 3, 2022
Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 – 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy®
Regulatory News:
By Median Technologies · Via Business Wire · September 6, 2022
Median Technologies: Financial Communication Schedule for the Second Half of 2022
Regulatory News:
By Median Technologies · Via Business Wire · July 25, 2022
Median Technologies Communicates Its Business Indicators for the Second Quarter of 2022
Regulatory News:
By Median Technologies · Via Business Wire · July 11, 2022
Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 – 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy®
Regulatory News:
By Median Technologies · Via Business Wire · July 8, 2022
Median Technologies to host a live webcast and provide a company update on July 12, 2022
Regulatory News:
By Median Technologies · Via Business Wire · July 7, 2022
Bryan Garnier & Co Initiates the Coverage of Median Technologies with a “Buy” Recommendation
Regulatory News:
By Median Technologies · Via Business Wire · June 13, 2022
Median Technologies to Present an Abstract at the 2022 ASCO Annual Meeting, June 3 – 7, 2022, McCormick Place, Chicago, IL, USA
Regulatory News:
By Median Technologies · Via Business Wire · June 2, 2022
Median Technologies Launches Imaging Lab, Spearheading the Integration of iBiopsy® Artificial Intelligence Technologies Into iCRO Imaging Services for Oncology Trials
Regulatory News:
By Median Technologies · Via Business Wire · May 31, 2022
Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 14, 2022
Regulatory News:
By Median Technologies · Via Business Wire · May 23, 2022
Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device
Regulatory News:
By Median Technologies · Via Business Wire · May 5, 2022
Median Technologies Reports Full-Year 2021 Results and Business Indicators for the First Quarter of 2022
Regulatory News:
By Median Technologies · Via Business Wire · April 21, 2022
Median Technologies Brings Forward Its 2021 Annual Results Publication to April 21, 2022
Regulatory News:
By Median Technologies · Via Business Wire · March 25, 2022
Median Technologies Announces Design Completion of its iBiopsy® Lung Cancer Screening End-to-end CADe/CADx Software as Medical Device (SaMD) with Outstanding Sensitivity & Specificity Performance
Regulatory News:
By Median Technologies · Via Business Wire · March 22, 2022
Median Technologies Announces 2021 Revenue of €20.5 Million, Up 52%, and a Strengthened Cash Position of €39 Million
Regulatory News:
By Median Technologies · Via Business Wire · January 17, 2022
Median Technologies Announces Outstanding Lung Nodule Detection (CADe1) Performance for iBiopsy® Lung Cancer Screening
Regulatory News:
By Median Technologies · Via Business Wire · January 5, 2022
Median Technologies: Financial Communications Schedule for the First Half of 2022
Regulatory News:
By Median Technologies · Via Business Wire · January 4, 2022
Median Technologies Announces New Outstanding Performance for its iBiopsy® Lung Cancer Screening CADx1 With a Focus on Stage 1 Lung Cancer Characterization
Regulatory News:
By Median Technologies · Via Business Wire · November 23, 2021
Median Technologies Reports on Its 2021 Half-Year Results and Its Q3 2021 Business Activity Indicators
Regulatory News:
By Median Technologies · Via Business Wire · October 21, 2021
Median Technologies to Host a Live Webcast and Provide a Company Update on October 25th, 2021
Regulatory News:
By Median Technologies · Via Business Wire · October 13, 2021
Median Technologies Has Been Confirmed as a Preferred Vendor by one of the Top 3 Pharmaceutical Companies in the World, and Selected to Implement Their Clinical Trial Imaging Strategy on Some Key Oncology Indications
Regulatory News:
By Median Technologies · Via Business Wire · September 16, 2021
Median Technologies Changes the Publication Date of Its H1 2021 Results
Regulatory News:
By Median Technologies · Via Business Wire · September 14, 2021
Median Technologies Announces Outstanding Performance for its iBiopsy® Lung Cancer Screening CADx1 to Accurately Characterize Malignant vs Benign Lung Nodules Based on a Large-scale Patient Cohort
Regulatory News:
By Median Technologies · Via Business Wire · September 6, 2021
Median Technologies Appoints Jean-Christophe Montigny as Chief Financial Officer and Member of the Executive Committee
Regulatory News:
By Median Technologies · Via Business Wire · July 29, 2021
Median Technologies: Financial Communication Schedule for the Second Half Of 2021
Regulatory News:
By Median Technologies · Via Business Wire · July 9, 2021
Median Technologies' Business Continues to Grow at a Steady Pace in the First Half of 2021 (Unaudited Figures)
Regulatory News:
By Median Technologies · Via Business Wire · July 8, 2021
Median Technologies Is Releasing Full Year 2020 Financial Results (audited) as Well as Q1 2021 Business Activity Indicators, Showing a Very Strong Growth
Regulatory News:
By Median Technologies · Via Business Wire · April 8, 2021